-
Something wrong with this record ?
Peroxisome proliferator-activated receptor-γ stimulates 11β-hydroxysteroid dehydrogenase type 1 in rat vascular smooth muscle cells
K. Vagnerová, J. Loukotová, P. Ergang, J. Musílková, I. Mikšík, J. Pácha,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- 11-beta-Hydroxysteroid Dehydrogenase Type 1 genetics metabolism MeSH
- Enzyme Activation MeSH
- Enzyme Assays MeSH
- Transcription, Genetic MeSH
- Corticosterone pharmacology MeSH
- Rats MeSH
- Cells, Cultured MeSH
- Myocytes, Smooth Muscle drug effects enzymology MeSH
- Rats, Wistar MeSH
- PPAR gamma agonists metabolism MeSH
- Muscle, Smooth, Vascular cytology MeSH
- Thiazolidinediones pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Glucocorticoids are metabolized in vascular tissue by two types of 11β-hydroxysteroid dehydrogenases (11HSD1, 11HSD2) and thus these enzymes are considered to be important factors that modulate the diverse and complex effects of glucocorticoids on cardiovascular function. The present study evaluated the effect of peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone on 11HSD1 vascular smooth muscle cells (VSMC) and compared the effect with that of corticosterone. Using primary cultures of VSMC derived from rat aorta, we showed that pioglitazone significantly increases 11HSD1 activity and mRNA expression in a dose-dependent manner with EC(50) 243 nM and that this effect is not blocked by RU 486, an antagonist of the glucocorticoid receptor. In contrast, corticosterone had no effect on 11HSD1. Pioglitazone positively regulated transcription of two CCAAT/enhancer-binding proteins (C/EBPs), specifically C/EBPα a potent activator of 11HSD1 gene transcription in some cells types, and C/EBPζ, whereas C/EBPβ and C/EBPδ were not changed. In contrast, corticosterone stimulated the expression of C/EBPβ and C/EBPδ, but the levels of C/EBPα and C/EBPζ were not changed. In conclusion, activation of PPARγ in VSMC up-regulates vascular 11HSD1 and thus reactivates 11-oxo metabolites to biologically active glucocorticoids through a mechanism that seems to involve C/EBPα and C/EBPζ. Our data provide one of the possible explanations for PPARγ agonists' effects on the cardiovascular system.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028429
- 003
- CZ-PrNML
- 005
- 20121210111321.0
- 007
- ta
- 008
- 120817e20110223xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.steroids.2011.02.008 $2 doi
- 035 __
- $a (PubMed)21352843
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vagnerová, Karla $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 245 10
- $a Peroxisome proliferator-activated receptor-γ stimulates 11β-hydroxysteroid dehydrogenase type 1 in rat vascular smooth muscle cells / $c K. Vagnerová, J. Loukotová, P. Ergang, J. Musílková, I. Mikšík, J. Pácha,
- 520 9_
- $a Glucocorticoids are metabolized in vascular tissue by two types of 11β-hydroxysteroid dehydrogenases (11HSD1, 11HSD2) and thus these enzymes are considered to be important factors that modulate the diverse and complex effects of glucocorticoids on cardiovascular function. The present study evaluated the effect of peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone on 11HSD1 vascular smooth muscle cells (VSMC) and compared the effect with that of corticosterone. Using primary cultures of VSMC derived from rat aorta, we showed that pioglitazone significantly increases 11HSD1 activity and mRNA expression in a dose-dependent manner with EC(50) 243 nM and that this effect is not blocked by RU 486, an antagonist of the glucocorticoid receptor. In contrast, corticosterone had no effect on 11HSD1. Pioglitazone positively regulated transcription of two CCAAT/enhancer-binding proteins (C/EBPs), specifically C/EBPα a potent activator of 11HSD1 gene transcription in some cells types, and C/EBPζ, whereas C/EBPβ and C/EBPδ were not changed. In contrast, corticosterone stimulated the expression of C/EBPβ and C/EBPδ, but the levels of C/EBPα and C/EBPζ were not changed. In conclusion, activation of PPARγ in VSMC up-regulates vascular 11HSD1 and thus reactivates 11-oxo metabolites to biologically active glucocorticoids through a mechanism that seems to involve C/EBPα and C/EBPζ. Our data provide one of the possible explanations for PPARγ agonists' effects on the cardiovascular system.
- 650 _2
- $a 11-beta-hydroxysteroiddehydrogenasa typ 1 $x genetika $x metabolismus $7 D043205
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a kortikosteron $x farmakologie $7 D003345
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a enzymatické testy $7 D057075
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a svaly hladké cévní $x cytologie $7 D009131
- 650 _2
- $a myocyty hladké svaloviny $x účinky léků $x enzymologie $7 D032389
- 650 _2
- $a PPAR gama $x agonisté $x metabolismus $7 D047495
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a thiazolidindiony $x farmakologie $7 D045162
- 650 _2
- $a genetická transkripce $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Loukotová, Jana
- 700 1_
- $a Ergang, Peter
- 700 1_
- $a Musílková, Jana
- 700 1_
- $a Mikšík, Ivan
- 700 1_
- $a Pácha, Jiří
- 773 0_
- $w MED00004438 $t Steroids $x 1878-5867 $g Roč. 76, č. 6 (20110223), s. 577-81
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21352843 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210111358 $b ABA008
- 999 __
- $a ok $b bmc $g 950471 $s 785775
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 76 $c 6 $d 577-81 $e 20110223 $i 1878-5867 $m Steroids $n Steroids $x MED00004438
- LZP __
- $a Pubmed-20120817/11/04
